Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ZSPC vs BHST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

BHST Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–2 Matrix Metrics)

BHST Overall Winner 6-Pillar Tally: ZSPC 0 – 5 BHST (1 Tie) Matrix Metrics: ZSPC 2 – 6 BHST

As of Nov 20, 2026, BioHarvest Sciences Inc. (BHST) is the stronger overall head-to-head candidate over zSpace, Inc. (ZSPC) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ZSPC carries a Unified Composite Score of 59.8/100 (HOLD) at $0.24 (N/M Forward P/E, -116.2% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin).

  • Composite vs. Pillar Nuance: While ZSPC currently prints a higher short-term Unified Composite Score (59.8/100 HOLD vs. BHST 58.2/100 HOLD), BHST captures the overall institutional head-to-head verdict (6–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-18.0% vs. -116.2% operating margin) and revenue trajectory (+3.8% vs. -43.2% YoY).
  • Technical & Structure Timing Caution: ZSPC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.2); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ZSPC vs BHST
ZSPC NASDAQ
zSpace, Inc. Common stock
Services-Prepackaged Software
$0.24
-45.79% 1D
Market Cap $1.3M
TTM Revenue $28M
Forward P/E N/M
Beta / 30D Vol -10.63β · 6994% Vol
Unified Composite Score
59.8 / 100 HOLD
Tech 60.0 Fund 57.0 Flow 50.0 Mom 58.5
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -24.8%) with fading momentum, RSI 48
RSI-14: 48.2 · SMA20: $0.25 · SMA50: $0.23
BHST NASDAQ Head-to-Head Winner
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58

6-Pillar Scorecard Institutional Category Breakdown (ZSPC 0 – 5 BHST)

Columns: Metric · ZSPC · BHST
1. Valuation Multiples BHST
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.7x
2. Growth & Scale BHST
Revenue Growth (YoY) -43.2% +3.8%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $28M $35M
Market Cap $1.3M $29.9M
3. Profitability & Quality BHST
Gross Margin 47.6% 59.0%
Operating Margin -116.2% -18.0%
Net Profit Margin -91.1% -31.2%
Return on Equity (ROE) 0.0% -142.5%
4. Balance Sheet & Cash Flow BHST
Cash Generation (TTM) -$22M EBITDA -$9.4M
Cash Flow Margin -79.4% EBITDA Mgn -26.6%
Net Cash / Leverage 0.0% ROE $5.1M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity N/A 77.0% of Rev ($27M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Computer Hardware Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ZSPC (2) vs BHST (6)
Institutional Metric ZSPC BHST Criterion Row Edge
Market Capitalization
Scale
$1.3M $29.9M Larger Scale BHST
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-43.2% +3.8% Higher Growth BHST
Operating Margin (TTM)
Profitability
-116.2% -18.0% Higher Margin BHST
Net Profit Margin
Profitability
-91.1% -31.2% Higher Margin BHST
Return on Equity (ROE)
Capital Efficiency
0.0% -142.5% Higher ROE ZSPC
52-Week Range Position
Momentum
2% ($0–$10) 6% ($1–$7) Stronger Trend BHST
Beta / 30D Volatility
Risk Regime
-10.63β · 6994% Vol 0.25β · 86% Vol Lower Realized Risk BHST
Unified Institutional Score
Composite Signal
59.8 / 100 (HOLD) 58.2 / 100 (HOLD) Higher Composite ZSPC
Trailing 12M Revenue (USD)
Operating Scale
$28M $35M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
47.6% 59.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$22M EBITDA (0.0% ROE) -$9.4M ($5.1M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ZSPC +69.68 pp
ZSPC: +71.07% · BHST: +1.39%
3M Horizon BHST +38.35 pp
ZSPC: -53.63% · BHST: -15.28%
6M Horizon BHST +30.61 pp
ZSPC: -61.2% · BHST: -30.59%
1Y Horizon BHST +30.61 pp
ZSPC: -61.2% · BHST: -30.59%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ZSPC Revenue BHST Revenue ZSPC Op. Margin BHST Op. Margin Margin Leader
FY2023 N/A $10M N/A -78.6% BHST
FY2024 $40M $30M -46.3% -27.7% BHST
FY2025 $30M $30M -79.5% -16.2% BHST

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ZSPC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ZSPC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ZSPC Moat Profile Cyclical / Execution-Driven Positioning
Computer Hardware Operator
Competes within the Computer Hardware value chain with $1.3M market capitalization and -116.2% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published

Investor FAQ ZSPC vs BHST Key Questions & Quantitative Answers

As of Nov 20, 2026, BioHarvest Sciences Inc. (BHST) is the stronger overall head-to-head candidate over zSpace, Inc. (ZSPC) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ZSPC carries a Unified Composite Score of 59.8/100 (HOLD) at $0.24 (N/M Forward P/E, -116.2% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While ZSPC currently prints a higher short-term Unified Composite Score (59.8/100 HOLD vs. BHST 58.2/100 HOLD), BHST captures the overall institutional head-to-head verdict (6–2 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-18.0% vs. -116.2% operating margin) and revenue trajectory (+3.8% vs. -43.2% YoY). Technical & Structure Timing Caution: ZSPC is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 48.2); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BHST leads the Growth & Scale pillar: ZSPC posts -43.2% YoY revenue growth and +0.0% YoY earnings growth on $28M TTM revenue (47.6% gross margin, -116.2% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). Across the 3-period historical trajectory (FY2023 to FY2025), ZSPC cumulative revenue shifted -25.0% while BHST shifted +200.0%. In operating R&D and SG&A reinvestment, ZSPC deploys N/A (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.

BHST screens cheaper on headline valuation multiples. ZSPC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-79.4% EBITDA margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ZSPC (0.0% ROE) versus BHST (-142.5% ROE) capital efficiency.

In options market volatility and institutional positioning, ZSPC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-10.63β · 6994% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.